MiNA Therapeutics
PrivateLast Round
Corporate Funding
Jul 6, 2021
Est. Valuation
$176.56M
Total Funding Raised
$90.73M
Company Overview
MiNA Therapeutics is a biotechnology company that develops small activating RNA (saRNA) therapeutics to restore or enhance gene function for the treatment of cancer and severe genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MiNA Therapeutics Comparables
Compare MiNA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ractigen Therapeutics | 85% | |
| CAMP4 | 79% | |
| Bristol Myers Squibb | 71% | |
MiNA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 6, 2021 | ||||
| Series A | Sep 10, 2020 | ||||
| Grant | Nov 2, 2017 | ||||
| Strategic | May 3, 2017 |
Key People
Founding team and executive leadership
MiNA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| aMoon | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 12, 2025
New data from sickle cell disease program presented at EHA 2025 Congress.
- Jun 12, 2025
Presented at the European Hematology Association 2025 Congress.
MiNA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MiNA Therapeutics's valuation, stock price, and market status.